FDA issues blindness warning for Ozempic, Mounjaro and other GLP-1s
The FDA has issued a new warning for popular weight-loss and diabetes drugs after disturbing reports of users experiencing “Ozempic blindness.” For nearly four decades, Ed Gillen worked for the state highway department while raising ...